Shenzhen Detianbao Pharmaceutical Development Co., Ltd. is a limited liability company (sole proprietorship of natural persons) registered in Futian District, Shenzhen City, Guangdong Province on May 16, 2014. Its registered address is on Yuanling Street, Futian District, Shenzhen City Room 2221, Qingfeng Rongsheng Venture Capital Building, No. 88-8 Bagua 3rd Road, Lin Community.
The unified social credit code/registration number of Shenzhen Detianbao Pharmaceutical Development Co., Ltd. is 914403003060168496. The corporate legal person is Xie Mingrui. The company is currently in business.
The business scope of Shenzhen Detianbao Pharmaceutical Development Co., Ltd. is: general business items are: purchase and sale of nourishing and health-care Chinese medicinal materials; sales of health-care equipment; property management, leasing of own properties; cosmetics, sanitary products, Sales of disinfectants; domestic trade, import and export business. (Except for items prohibited by laws, administrative regulations, and decisions of the State Council, restricted items must obtain a license before they can be operated). The licensed business items are: Class I medical devices, Class II medical devices (including only in vitro diagnostic reagents stored at room temperature); III Class medical devices: 6815 injection puncture instruments, 6821 medical electronic instruments and equipment, 6823 medical ultrasound instruments and related equipment, 6824 medical laser instruments and equipment, 6825 medical high-frequency instruments and equipment, 6826 physical therapy and rehabilitation equipment, 6854 operating rooms, emergency rooms, Clinic equipment and appliances, 6863 dental materials, 6866 medical polymer materials and products, 6864 wholesale and retail of medical sanitary materials and dressings. In Guangdong Province, the total registered capital of companies with similar business scope is 27,246.04 million yuan, and the main capital is concentrated in 8,404 enterprises with a scale of 1 to 10 million and 10 to 50 million.
View more information and information about Shenzhen Detianbao Pharmaceutical Development Co., Ltd. through Aiqicha.